SCHEMBL4443137

SCHEMBL4443137

N#Cc1nnc(N2CCN(C(=O)O)CC2)cc1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
CSNK1D P48730 3/20 0.42
MAPK14 Q16539 3/20 0.42
LMNA P02545 3/20 0.42
TSHR P16473 1/20 0.42
SMO Q99835 1/20 0.40
SLC6A7 Q99884 4/20 0.39
MAPK11 Q15759 1/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
MAPK1 P28482 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CKS1B P61024 4/20 0.38
SKP1 P63208 4/20 0.38
SKP2 Q13309 4/20 0.38
MET P08581 2/20 0.37
CXCR3 P49682 1/20 0.37
KCNH2 Q12809 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2951404 0.84 CKS1B (0.54) CKS1BSKP1SKP2
SCHEMBL4438731 0.81 ALDH1A1 (0.44) ALDH1A1CSNK1DMAPK14LMNATSHR
SCHEMBL2967476 0.81 CSNK1D (0.60) CSNK1DMAPK14LMNAMAPK11
SCHEMBL19748343 0.72 PANK3 (0.59)
SCHEMBL5238054 0.70 HTR1A (0.57) ALDH1A1LMNATSHRSLC6A7KDM4E
SCHEMBL4443140 0.68 KDM4E (0.41) ALDH1A1CSNK1DMAPK14LMNASMO
SCHEMBL20140586 0.68 PARP1 (0.44) ALDH1A1LMNATSHRL3MBTL1
SCHEMBL3442387 0.68 ALDH1A1 (0.56) ALDH1A1LMNATSHRSLC6A7KDM4E
SCHEMBL1686083 0.68 MET (0.45) ALDH1A1LMNATSHRSLC6A7KDM4E
SCHEMBL4443105 0.68 KDM4E (0.40) ALDH1A1CSNK1DMAPK14LMNASMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121630-A1 FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS Janssen Pharmaceutica, N.V. (BE) 2009-11-25 EP disclosed
WO-2008098892-A1 FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-08-21 WO disclosed